Interferon-α increases monocyte migration via platelet-monocyte interaction in murine intestinal microvessels

Clinical and Experimental Immunology

Volumn 162, Issue 1, 2010, Pages 156-162

  Higashiyama, M ^a   Hokari, R ^a   Kurihara, C ^a   Ueda, T ^a   Nakamura, M ^a   Komoto, S ^a   Okada, Y ^a   Watanabe, C ^a   Kawaguchi, A ^a   Nagao, S ^a   Miura, S ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

ileum; inflammation; interferon; mice; monocytes; platelets

Indexed keywords

ALPHA INTERFERON; FLUORESCEIN; PADGEM PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; MALE; MICROCIRCULATION; MICROVASCULATURE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTOPENIA; VASCULAR ENDOTHELIUM; VENULE;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD PLATELETS; CELL ADHESION; CELL COMMUNICATION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; INTERFERON-ALPHA; INTESTINE, SMALL; LEUKOCYTE ROLLING; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MICROVESSELS; MONOCYTES; P-SELECTIN; THROMBOCYTOPENIA;

EID: 77956512508     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04222.x     Document Type: Article

References (28)

1. Gutterman JU. Cytokine therapeutics: lessons from interferon alpha. Proc Natl Acad Sci USA 1994 91 : 1198 1205.
2. Schandene L, Del Prete GF, Cogan E et al. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J Clin Invest 1996 97 : 309 315.
3. Kaser A, Molnar C, Tilg H. Differential regulation of interleukin 4 and interleukin 13 production by interferon alpha. Cytokine 1998 10 : 75 81.
4. Sumer N, Palabiyikoglu M. Induction of remission by interferon-alpha in patients with chronic active ulcerative colitis. Eur J Gastroenterol Hepatol 1995 7 : 597 602.
5. Madsen SM, Schlichting P, Davidsen B et al. An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis. Am J Gastroenterol 2001 96 : 1807 1815.
6. Guyer DR, Tiedeman J, Yannuzzi LA et al. Interferon-associated retinopathy. Arch Ophthalmol 1993 111 : 350 356.
7. Sonnenblick M, Rosin A. Cardiotoxicity of interferon. A review of 44 cases. Chest 1991 99 : 557 561.
8. Grunberg SM, Kempf RA, Itri LM, Venturi CL, Boswell WD Jr., Mitchell MS. Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma. Cancer Treat Rep 1985 69 : 1031 1032.
9. Ishii N, Tsuzuki Y, Matsuzaki K et al. Endotoxin stimulates monocyte-endothelial cell interactions in mouse intestinal Peyer's patches and villus mucosa. Clin Exp Immunol 2004 135 : 226 232.
10. Inoue T, Tsuzuki Y, Matsuzaki K et al. Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice. J Leukoc Biol 2005 77 : 287 295.
11. Higashiyama M, Hokari R, Matsunaga H et al. P-selectin-dependent monocyte recruitment through platelet interaction in intestinal microvessels of LPS-treated mice. Microcirculation 2008 15 : 441 450.
12. Kamada N, Hisamatsu T, Okamoto S et al. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol 2005 175 : 6900 6908.
13. Ishikawa M, Cooper D, Russell J et al. Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke 2003 34 : 1777 1782.
14. Tailor A, Granger DN. Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules. Arterioscler Thromb Vasc Biol 2003 23 : 675 680.
15. Matsunaga H, Hokari R, Higashiyama M et al. Cilostazol, a specific PDE-3 inhibitor, ameliorates chronic ileitis via suppression of interaction of platelets with monocytes. Am J Physiol Gastrointest Liver Physiol 2009 297 : G1077 84. Epub 2009 Oct 8.
16. Lim YC, Snapp K, Kansas GS, Camphausen R, Ding H, Luscinskas FW. Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-alpha-activated endothelium under flow in vitro. J Immunol 1998 161 : 2501 2508.
17. Sieghart W, Homoncik M, Jilma B et al. Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis C. Thromb Haemost 2006 95 : 260 266.
18. Nishiguchi S, Kuroki T, Nakatani S et al. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995 346 : 1051 1055.
19. Iacobelli S, Garufi C, Irtelli L et al. A phase I study of recombinant interferon-alpha administered as a seven-day continuous venous infusion at circadian-rhythm modulated rate in patients with cancer. Am J Clin Oncol 1995 18 : 27 31.
20. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU. Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 1986 4 : 234 243.
21. Danese S, Fiocchi C. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol 2006 12 : 4807 4812.
22. Tilg H, Vogelsang H, Ludwiczek O et al. A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut 2003 52 : 1728 1733.
23. Mitoro A, Yoshikawa M, Yamamoto K et al. Exacerbation of ulcerative colitis during alpha-interferon therapy for chronic hepatitis C. Intern Med 1993 32 : 327 331. (Pubitemid 23282340)
24. Mavrogiannis C, Papanikolaou IS, Elefsiniotis IS, Psilopoulos DI, Karameris A, Karvountzis G. Ulcerative colitis associated with interferon treatment for chronic hepatitis C. J Hepatol 2001 34 : 964 965.
25. Khalil A, Lucidarme D, Desurmont P, Hamdan-Khalil R, Filoche B. [Crohn's disease associated with interferon and ribavirin treatment for chronic hepatitis C]. Gastroenterol Clin Biol 2005 29 : 193 196. (Pubitemid 40385081)
26. Sprenger R, Sagmeister M, Offner F. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis. Gut 2005 54 : 438 439.
27. Gasche C, Reinisch W, Vogelsang H et al. Prospective evaluation of interferon-alpha in treatment of chronic active Crohn's disease. Dig Dis Sci 1995 40 : 800 804.
28. Seow CH, Benchimol EI, Griffiths AM, Steinhart AH. Type I interferons for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2008 issue 3 : CD006790.